Ramon L. Rodriguez, M.D.
Director, Movement Disorders Clinic
Director, Tyler’s Hope Center for Dystonia Care
Associate Professor of Neurology
100 S Newell Drive, Room L3-100
Gainesville, FL 32610
PO Box 100236
352-273-5550
FAX- 352-273-5575
Email Dr. Rodriguez
Ramon L. Rodriguez, MD, Director of the Movement Disorders Clinic and Clinical Trials Center, completed his B.S. in Biology from the University of Puerto Rico and graduated Magna Cum Laude from the University of Puerto Rico, School of Medicine in San Juan, PR. He went on to complete an Internal Medicine Internship and Neurology Residency at the University of Texas Medical Branch in Galveston, Texas. It was there that he developed an interest in Parkinson’s disease and Movement Disorders and pursued a Fellowship in Movement Disorders and Surgery for Movement Disorders at the University of Florida Gainesville.
Besides his interests in surgery for movement disorders, Dr. Rodriguez has special interest in the translation of the latest advances in movement disorders research and the application into clinical practice. He is also experienced in the administration of Botulinum toxin for dystonia and spasticity. The main goal in his practice is to provide the highest level of care and improve the quality of life of his patients.
Dr. Rodriguez directs the Tyler’s Hope Dystonia Center at UF and the Huntington’s disease clinic.
In addition to clinical care, Dr. Rodriguez is investigator in multiple clinical trials attempting to find ways to delay the progression of Parkinson’s disease as well as development of new therapies. He is also an Associate Professor at the Department of Neurology and is Board Certified in Neurology by the American Board of Psychiatry and Neurology.
Dr. Rodriguez directs 30+ clinical trials and 7 full time clinical trials coordinators in the Center for Movement Disorders and Neurorestoration. He is author or co-author on more than 50 research publications. He travels the world lecturing on clinical trials, scales administration, botulinum toxin, and novel therapies for movement disorders.
